Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502997-18-00

Acronym

IM034-1014

Enrollment

Registered

2023-09-11

Start date

2024-02-02

Completion date

2025-11-06

Last updated

2025-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Czechia, France, Germany, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026